Cliff Asness's ANIK Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 69,280 shares of Anika Therapeutics, Inc. (ANIK) worth $665,781, representing 0.00% of the portfolio. First purchased in 2013-Q4, this long-term strategic position has been held for 44 quarters.
Based on 13F filings since 2013, Cliff Asness has maintained a long-term strategic position in ANIK, representing a significant commitment to this investment thesis. Largest addition occurred in Q3 2014, adding 116,000 shares. Largest reduction occurred in Q3 2024, reducing 76,681 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Anika Therapeutics (ANIK) Holding Value Over Time
Track share changes against reported price movement
Quarterly Anika Therapeutics (ANIK) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +19,817 | Add 40.06% | 69,280 | $9.61 |
| Q3 2025 | -1,351 | Reduce 2.66% | 49,463 | $9.40 |
| Q2 2025 | +38,757 | Add 321.45% | 50,814 | $10.58 |
| Q1 2025 | +12,057 | New Buy | 12,057 | $15.03 |
| Q4 2024 | -30,692 | Sold Out | 0 | $0.00 |
| Q3 2024 | -76,681 | Reduce 71.42% | 30,692 | $24.70 |
| Q2 2024 | +8,072 | Add 8.13% | 107,373 | $25.33 |
| Q1 2024 | +5,150 | Add 5.47% | 99,301 | $25.40 |
| Q4 2023 | +20,597 | Add 28.00% | 94,151 | $22.66 |
| Q3 2023 | +41,479 | Add 129.32% | 73,554 | $18.63 |
| Q2 2023 | +251 | Add 0.79% | 32,075 | $25.98 |
| Q1 2023 | -17 | Reduce 0.05% | 31,824 | $28.72 |
| Q4 2022 | +7,451 | Add 30.55% | 31,841 | $29.60 |
| Q3 2022 | +9,685 | Add 65.86% | 24,390 | $23.78 |
| Q2 2022 | +14,705 | New Buy | 14,705 | $22.31 |
| Q4 2020 | -53,796 | Sold Out | 0 | $0.00 |
| Q3 2020 | -63,996 | Reduce 54.33% | 53,796 | $35.39 |
| Q2 2020 | -3,655 | Reduce 3.01% | 117,792 | $37.73 |
| Q1 2020 | +31,368 | Add 34.82% | 121,447 | $28.91 |
| Q4 2019 | +54,668 | Add 154.38% | 90,079 | $51.85 |
| Q3 2019 | +29,398 | Add 488.91% | 35,411 | $54.90 |
| Q2 2019 | -9,869 | Reduce 62.14% | 6,013 | $40.58 |
| Q1 2019 | +775 | Add 5.13% | 15,882 | $30.22 |
| Q4 2018 | +177 | Add 1.19% | 15,107 | $33.63 |
| Q3 2018 | -14,193 | Reduce 48.73% | 14,930 | $42.13 |
| Q2 2018 | -14,253 | Reduce 32.86% | 29,123 | $32.00 |
| Q1 2018 | +552 | Add 1.29% | 43,376 | $49.73 |
| Q4 2017 | -4,455 | Reduce 9.42% | 42,824 | $53.92 |
| Q3 2017 | -5,461 | Reduce 10.35% | 47,279 | $58.00 |
| Q2 2017 | -9,600 | Reduce 15.40% | 52,740 | $49.36 |
| Q1 2017 | -51,336 | Reduce 45.16% | 62,340 | $43.44 |
| Q4 2016 | -34,675 | Reduce 23.37% | 113,676 | $48.96 |
| Q3 2016 | +43,754 | Add 41.83% | 148,351 | $47.85 |
| Q2 2016 | +48,713 | Add 87.17% | 104,597 | $53.64 |
| Q1 2016 | -47,453 | Reduce 45.92% | 55,884 | $44.72 |
| Q4 2015 | -17,358 | Reduce 14.38% | 103,337 | $38.16 |
| Q3 2015 | -63,619 | Reduce 34.52% | 120,695 | $31.82 |
| Q2 2015 | -17,537 | Reduce 8.69% | 184,314 | $33.03 |
| Q1 2015 | -22,301 | Reduce 9.95% | 201,851 | $41.17 |
| Q4 2014 | +62,529 | Add 38.69% | 224,152 | $40.74 |
| Q3 2014 | +116,000 | Add 254.26% | 161,623 | $36.66 |
| Q2 2014 | +3,700 | Add 8.83% | 45,623 | $46.34 |
| Q1 2014 | +32,600 | Add 349.67% | 41,923 | $41.10 |
| Q4 2013 | +9,323 | New Buy | 9,323 | $38.19 |
Cliff Asness's Anika Therapeutics Investment FAQs
Cliff Asness first purchased Anika Therapeutics, Inc. (ANIK) in Q4 2013, acquiring 9,323 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Anika Therapeutics, Inc. (ANIK) for 44 quarters since Q4 2013.
Cliff Asness's largest addition to Anika Therapeutics, Inc. (ANIK) was in Q3 2014, adding 161,623 shares worth $5.92 M.
According to the latest 13F filing for Q4 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 69,280 shares of Anika Therapeutics, Inc. (ANIK), valued at approximately $665,781.
As of the Q4 2025 filing, Anika Therapeutics, Inc. (ANIK) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Anika Therapeutics, Inc. (ANIK) was 224,152 shares, as reported at the end of Q4 2014.